Skip to content

To study the efficacy of a restricted diet in improving symptoms in patients with Irritable bowel syndrome

Role of low FODMAP diet in patients with Irritable bowel syndrome (IBS) : a randomized trial - FIBS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017450
Enrollment
100
Registered
2019-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K580- Irritable bowel syndrome with diarrhea

Interventions

Intervention1: Low FODMAP diet (fermentable oligosaccharides, monosaccharides, disaccharides and polyols): The low FODMAP diet implies a restricted intake of foods containing fermentable oligosacchari
to eat in peace and quiet and to chew thoroughly
reduce intake of fatty or spicy foods, coffee, alcohol, onions, cabbage and beans
avoid soft drinks and carbonated beverages, chewing gums and sweeteners that ends with â??ol, and to eat fibers but distribute the intake evenly over the day.

Sponsors

Department of Gastroenterology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. IBS-D diagnosed according to ROME IV criteria. 2. Age- 18-70 years 3. Currently having medium-severe symptoms [as indicated by IBS Symptom Severity Score (IBS-SSS) >=17.5]

Exclusion criteria

Exclusion criteria: 1. Presence of a severe cardiac, liver, neurological or psychiatric disease 2. Presence of another GI disease than IBS (e.g. inflammatory bowel disease, celiac disease) that could explain the current symptoms. 3. Patients with IBS â??Constipation predominant 4. Patients who are already on a diet excessively restricting certain nutrients before entering the study (e.g. low in FODMAPs, gluten-free, lactose free diet). 5. Prescription of bowel preparation for investigative procedures, antibiotic therapy, prebiotics or probiotics, and change to IBS medication during the previous four weeks.

Design outcomes

Primary

MeasureTime frame
Change in IBS-SSS (symptom severity score)Timepoint: 4 weeks

Secondary

MeasureTime frame
1. Change in stool frequency 2. Change in nutrient intakeTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Omesh Goyal

Dayanand Medical College and Hospital

goyalomesh@yahoo.co.in9914821155

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026